Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05173_nanopub.RA9MJaJanCKmWuTR73wMy0Y66VRUicpWa_8PtJQKq3_Ko#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05173 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05173 label "PTC299 [drugbank:DB05173]" assertion.
- drugbank:DB05173 seeAlso DB05173 assertion.
- drugbank:DB05173 description "PTC299 is a novel, orally administered small-molecule designed to inhibit the production of vascular endothelial growth factor (VEGF) in tumors. Overexpression of VEGF plays a key role in multiple diseases including cancer and macular degeneration. PTC299 was discovered through PTC's GEMS technology by targeting the post-transcriptional processes that regulate VEGF formation, and is currently being developed for the treatment of cancer." assertion.
- drugbank:DB05173 identifier "drugbank:DB05173" assertion.
- drugbank:DB05173 title "PTC299" assertion.
- drugbank:DB05173 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05173 drugbank_vocabulary:drugbank-id "DB05173" assertion.
- drugbank:DB05173 bio2rdf_vocabulary:x-identifiers.org DB05173 assertion.
- drugbank:DB05173 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05173" assertion.
- drugbank:DB05173 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05173 bio2rdf_vocabulary:identifier "DB05173" assertion.